From this discussion it can be inferred that a higher expression of Bax, Bak, Bim, or Bad is likely to confer tumor cells a survival advantage, whereas an increased expression of Bcl-2, Bcl-xL, or Mcl-1 is likely to be associated with a poorer prognosis. This evidence concerns the gene BCL2 and neoplasm.